Research carried out through University of Utah Health’s NICU and the Neonatal Follow-up Program (NFP) found ways to reduce the age of diagnosis for cerebral palsy from 19.5 months to...
U of U Health scientists developed and tested a new tool that assesses the social needs of ER patients and, if necessary, refers them to up to 46 community resources...
COVID-19 has shined a spotlight on the efforts of University of Utah Health’s Immunology, Inflammation and Infectious Disease (3i) initiative. 3i is a university-wide effort that brings scientists from diverse...
Award Amount: $250,000 - $500,000 Application Due Date: Letter of Intent Due June 8, 2020 Health Effects Institute is accepting applications for research on novel and important aspects of the...
Award Amount: Up to 500,000 EUR ($561,995 USD) per year for three years Application Due Date: Rolling The recent COVID-19 pandemic shows that pandemic preparedness and having the right products...
Award Amount: $22 million in direct costs (Feasibility phase: $2 million; Full-scale study phase: $20 million) Application Due Date: Letter of Intent Due September 29, 2020 (Portal opens June 9...
Award Amount: $1 Million over three years Application Due Date: Concept Papers Due June 19, 2020 The Office of the Vice President for Research is seeking interdisciplinary and transformative project...
ACT helps clinical investigators with discovering cohorts before the start of a trial, establishing the feasibility of a clinical protocol for grant applications, and with identifying patients from multiple sites.
A team of researchers at University of Utah Health has shown the Epstein-Barr virus—which causes mononucleosis and is linked to the development of several cancers—uses a novel strategy to survive...
